AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model
Authors: Tahtis, K Lee, FT Smyth, FE Power, BE Renner, C Brechbiel, MW Old, LJ Hudson, PJ Scott, AM
Citation: K. Tahtis et al., Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model, CLIN CANC R, 7(4), 2001, pp. 1061-1072
Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcriptionfactor in angiomyolipomas
Authors: Jungbluth, AA King, R Fisher, DE Iversen, K Coplan, K Kolb, D Williamson, B Chen, YT Stockert, E Old, LJ Busam, KJ
Citation: Aa. Jungbluth et al., Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcriptionfactor in angiomyolipomas, APPL IMMUNO, 9(1), 2001, pp. 29-34
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: Results of a phase I trial
Authors: Scott, AM Lee, FT Hopkins, W Cebon, JS Wheatley, JM Liu, ZQ Smyth, FE Murone, C Sturrock, S MacGregor, D Hanai, N Inoue, K Yamasaki, M Brechbiel, MW Davis, ID Murphy, R Hannah, A Lim-Joon, M Chan, T Chong, G Ritter, G Hoffman, EW Burgess, AW Old, LJ
Citation: Am. Scott et al., Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: Results of a phase I trial, J CL ONCOL, 19(19), 2001, pp. 3976-3987
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients
Authors: Tanswell, P Garin-Chesa, P Rettig, WJ Welt, S Divgi, CR Casper, ES Finn, RD Larson, SM Old, LJ Scott, AM
Citation: P. Tanswell et al., Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients, BR J CL PH, 51(2), 2001, pp. 177-180
Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody
Authors: Lee, FT Hall, C Rigopoulos, A Zweit, J Pathmaraj, K O'Keefe, GJ Smyth, FE Welt, S Old, LJ Scott, AM
Citation: Ft. Lee et al., Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody, J NUCL MED, 42(5), 2001, pp. 764-769
Utilizing spatial information systems for non-spatial-data analysis
Authors: Old, LJ
Citation: Lj. Old, Utilizing spatial information systems for non-spatial-data analysis, SCIENTOMETR, 51(3), 2001, pp. 563-571
IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Authors: Shankaran, V Ikeda, H Bruce, AT White, JM Swanson, PE Old, LJ Schreiber, RD
Citation: V. Shankaran et al., IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, NATURE, 410(6832), 2001, pp. 1107-1111
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen
Authors: Ono, T Kurashige, T Harada, N Noguchi, Y Saika, T Niikawa, N Aoe, M Nakamura, S Higashi, T Hiraki, A Wada, H Kumon, H Old, LJ Nakayama, E
Citation: T. Ono et al., Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen, P NAS US, 98(6), 2001, pp. 3282-3287
Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity
Authors: Nishikawa, H Tanida, K Ikeda, H Sakakura, M Miyahara, Y Aota, T Mukai, K Watanabe, M Kuribayashi, K Old, LJ Shiku, H
Citation: H. Nishikawa et al., Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity, P NAS US, 98(25), 2001, pp. 14571-14576
Monophasic and biphasic synovial sarcomas abundantly express cancer/testisantigen NY-ESO-1 but not MAGE-A1 or CT7
Authors: Jungbluth, AA Antonescu, CR Busam, KJ Iversen, K Kolb, D Coplan, D Chen, YT Stockert, E Ladanyi, M Old, LJ
Citation: Aa. Jungbluth et al., Monophasic and biphasic synovial sarcomas abundantly express cancer/testisantigen NY-ESO-1 but not MAGE-A1 or CT7, INT J CANC, 94(2), 2001, pp. 252-256
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
Authors: Jungbluth, AA Chen, YT Stockert, E Busam, KJ Kolb, D Iversen, K Coplan, K Williamson, B Altorki, N Old, LJ
Citation: Aa. Jungbluth et al., Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues, INT J CANC, 92(6), 2001, pp. 856-860
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library
Authors: Jager, D Stockert, E Gure, AO Scanlan, MJ Karbach, J Jager, E Knuth, A Old, LJ Chen, YT
Citation: D. Jager et al., Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library, CANCER RES, 61(5), 2001, pp. 2055-2061
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001)
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001), CANCER RES, 61(20), 2001, pp. 7703-7703
Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33
Authors: Ritter, G Cohen, LS Williams, C Richards, EC Old, LJ Welt, S
Citation: G. Ritter et al., Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33, CANCER RES, 61(18), 2001, pp. 6851-6859
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor, CANCER RES, 61(14), 2001, pp. 5349-5354
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR
Authors: Luwor, RB Johns, TG Murone, C Huang, HJS Cavenee, WK Ritter, G Old, LJ Burgess, AW Scott, AM
Citation: Rb. Luwor et al., Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR, CANCER RES, 61(14), 2001, pp. 5355-5361
NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade
Authors: Kurashige, T Noguchi, Y Saika, T Ono, T Nagata, Y Jungbluth, A Ritter, G Chen, YT Stockert, E Tsushima, T Kumon, H Old, LJ Nakayama, E
Citation: T. Kurashige et al., NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade, CANCER RES, 61(12), 2001, pp. 4671-4674
Specific localization, gamma camera imaging, and intracellular traffickingof radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871in SK-MEL-28 melanoma xenografts
Authors: Lee, FT Rigopoulos, A Hall, C Clarke, K Cody, SH Smyth, FE Liu, ZQ Brechbiel, MW Hanai, N Nice, EC Catimel, B Burgess, AW Welt, S Ritter, G Old, LJ Scott, AM
Citation: Ft. Lee et al., Specific localization, gamma camera imaging, and intracellular traffickingof radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871in SK-MEL-28 melanoma xenografts, CANCER RES, 61(11), 2001, pp. 4474-4482
Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: Enhanced activity when combined with taxol chemotherapy
Authors: Clarke, K Lee, FT Brechbiel, MW Smyth, FE Old, LJ Scott, AM
Citation: K. Clarke et al., Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: Enhanced activity when combined with taxol chemotherapy, CLIN CANC R, 6(9), 2000, pp. 3621-3628
Eradication of established tumors by CD8(+) T cell adoptive immunotherapy
Authors: Hanson, HL Donermeyer, DL Ikeda, H White, JM Shankaran, V Old, LJ Shiku, H Schreiber, RD Allen, PM
Citation: Hl. Hanson et al., Eradication of established tumors by CD8(+) T cell adoptive immunotherapy, IMMUNITY, 13(2), 2000, pp. 265-276
Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: Frequency of expression and correlation with prognostic parameters
Authors: Busam, KJ Iversen, K Berwick, M Spagnoli, GC Old, LJ Jungbluth, AA
Citation: Kj. Busam et al., Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: Frequency of expression and correlation with prognostic parameters, MOD PATHOL, 13(4), 2000, pp. 459-465
SEREX analysis of gastric cancer antigens
Authors: Obata, Y Takahashi, T Sakamoto, J Tamaki, H Tominaga, S Hamajima, N Chen, YT Old, LJ
Citation: Y. Obata et al., SEREX analysis of gastric cancer antigens, CANC CHEMOT, 46, 2000, pp. S37-S42
T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues
Authors: Jungbluth, AA Iversen, K Coplan, K Kolb, D Stockert, E Chen, YT Old, LJ Busam, K
Citation: Aa. Jungbluth et al., T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues, PATH RES PR, 196(4), 2000, pp. 235-242
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9
Authors: Scanlan, MJ Altorki, NK Gure, AO Williamson, B Jungbluth, A Chen, YT Old, LJ
Citation: Mj. Scanlan et al., Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9, CANCER LETT, 150(2), 2000, pp. 155-164
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
Authors: Jager, E Nagata, Y Gnjatic, S Wada, H Stockert, E Karbach, J Dunbar, PR Lee, SY Jungbluth, A Jager, D Arand, M Ritter, C Cerundolo, V Dupont, B Chen, YT Old, LJ Knuth, A
Citation: E. Jager et al., Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses, P NAS US, 97(9), 2000, pp. 4760-4765
Risultati: 1-25 | 26-50